{"entity":{"type":"insider","cik":"0001693134","url":"/insider/0001693134","json_url":"/insider/0001693134.json","name":"Levy Adam Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":13,"first":"2017-06-23","last":"2026-01-13","span_basis":"filed_date"},"name_variants":[{"name":"Levy Adam Scott","source":"filing","n_filings":13,"first_seen":"2017-06-23","last_seen":"2026-01-13"}],"transactions":[{"id":5988038,"accession":"0001693134-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001693134-26-000002","line_url":"/filing/0001693134-26-000002#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10758.0,"shares_display":"10,758","price_per_share":32.1364,"price_display":"32.14","price_state":"stated","total_value":345723.3912,"total_display":"345,723.39","total_whole":"345,723","shares_owned_after":8638.0,"shares_owned_after_display":"8,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-13","scope":"insider"},{"id":4324378,"accession":"0001933414-25-000152","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001933414-25-000152","line_url":"/filing/0001933414-25-000152","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119524.0,"shares_display":"119,524","price_per_share":44.87563907416084,"price_display":"44.88","price_state":"stated","total_value":5363715.8847,"total_display":"5,363,715.88","total_whole":"5,363,716","shares_owned_after":52114.0,"shares_owned_after_display":"52,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider","n_lines":9},{"id":4039099,"accession":"0001933414-25-000130","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000130","line_url":"/filing/0001933414-25-000130","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10758.0,"shares_display":"10,758","price_per_share":42.013716285554935,"price_display":"42.01","price_state":"stated","total_value":451983.5598,"total_display":"451,983.56","total_whole":"451,984","shares_owned_after":120257.0,"shares_owned_after_display":"120,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-15","scope":"insider","n_lines":2},{"id":5135508,"accession":"0001933414-25-000081","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001933414-25-000081","line_url":"/filing/0001933414-25-000081","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59925.0,"shares_display":"59,925","price_per_share":14.757974593241553,"price_display":"14.76","price_state":"stated","total_value":884371.6275,"total_display":"884,371.63","total_whole":"884,372","shares_owned_after":141359.0,"shares_owned_after_display":"141,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-30","filed_date":"2025-07-30","scope":"insider","n_lines":2},{"id":5135498,"accession":"0001933414-25-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000081","line_url":"/filing/0001933414-25-000081#line-2","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":807.0,"shares_display":"807","price_per_share":14.0048,"price_display":"14.00","price_state":"stated","total_value":11301.8736,"total_display":"11,301.87","total_whole":"11,302","shares_owned_after":192859.0,"shares_owned_after_display":"192,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-30","scope":"insider"},{"id":5135494,"accession":"0001933414-25-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000081","line_url":"/filing/0001933414-25-000081#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12946.0,"shares_display":"12,946","price_per_share":14.0432,"price_display":"14.04","price_state":"stated","total_value":181803.2672,"total_display":"181,803.27","total_whole":"181,803","shares_owned_after":193666.0,"shares_owned_after_display":"193,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":5062547,"accession":"0001933414-25-000077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000077","line_url":"/filing/0001933414-25-000077#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10758.0,"shares_display":"10,758","price_per_share":14.4501,"price_display":"14.45","price_state":"stated","total_value":155454.1758,"total_display":"155,454.18","total_whole":"155,454","shares_owned_after":206612.0,"shares_owned_after_display":"206,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-11","filed_date":"2025-07-15","scope":"insider"},{"id":5135489,"accession":"0001933414-25-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-25-000046","line_url":"/filing/0001933414-25-000046#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10757.0,"shares_display":"10,757","price_per_share":12.0558,"price_display":"12.06","price_state":"stated","total_value":129684.2406,"total_display":"129,684.24","total_whole":"129,684","shares_owned_after":215340.0,"shares_owned_after_display":"215,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-11","filed_date":"2025-04-15","scope":"insider"},{"id":4607100,"accession":"0001933414-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-25-000005","line_url":"/filing/0001933414-25-000005","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10757.0,"shares_display":"10,757","price_per_share":9.097694887050293,"price_display":"9.10","price_state":"stated","total_value":97863.9039,"total_display":"97,863.90","total_whole":"97,864","shares_owned_after":226197.0,"shares_owned_after_display":"226,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-15","scope":"insider","n_lines":2},{"id":2811496,"accession":"0001933414-24-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000047","line_url":"/filing/0001933414-24-000047#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10757.0,"shares_display":"10,757","price_per_share":13.5729,"price_display":"13.57","price_state":"stated","total_value":146003.6853,"total_display":"146,003.69","total_whole":"146,004","shares_owned_after":236854.0,"shares_owned_after_display":"236,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-15","scope":"insider"},{"id":2617927,"accession":"0001933414-24-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000034","line_url":"/filing/0001933414-24-000034#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10757.0,"shares_display":"10,757","price_per_share":13.1444,"price_display":"13.14","price_state":"stated","total_value":141394.3108,"total_display":"141,394.31","total_whole":"141,394","shares_owned_after":247611.0,"shares_owned_after_display":"247,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-12","scope":"insider"},{"id":2833410,"accession":"0001933414-24-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001933414-24-000027","line_url":"/filing/0001933414-24-000027#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96815.0,"shares_display":"96,815","price_per_share":12.9393,"price_display":"12.94","price_state":"stated","total_value":1252718.3295,"total_display":"1,252,718.33","total_whole":"1,252,718","shares_owned_after":255462.0,"shares_owned_after_display":"255,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-13","scope":"insider"},{"id":8007626,"accession":"0001628280-23-003924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-003924","line_url":"/filing/0001628280-23-003924#line-1","is_derivative":false,"issuer_cik":"0001693134","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001693134","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (CFO, Chief Bus. Off. and Secy)","role_mark":"O","role_mark_label":"Officer (CFO, Chief Bus. Off. and Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, Chief Bus. Off. and Secy.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":350811.0,"shares_owned_after_display":"350,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider"},{"id":6331108,"accession":"0001209191-18-009625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-009625","line_url":"/filing/0001209191-18-009625#line-1","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"MIRAGEN THERAPEUTICS, INC.","issuer_ticker":"MGEN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9090.0,"shares_display":"9,090","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":49995.0,"total_display":"49,995.00","total_whole":"49,995","shares_owned_after":10540.0,"shares_owned_after_display":"10,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-13","filed_date":"2018-02-13","scope":"insider"},{"id":4446629,"accession":"0001209191-17-041768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-041768","line_url":"/filing/0001209191-17-041768#line-1","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"MIRAGEN THERAPEUTICS, INC.","issuer_ticker":"MGEN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001693134","owner_name":"Levy Adam Scott","owner_display_name":"Levy Adam Scott","owner_url":"/insider/0001693134","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":7.55,"price_display":"7.55","price_state":"stated","total_value":1510.0,"total_display":"1,510.00","total_whole":"1,510","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Officer (CFO and Secretary)","n_filings":11,"first_seen":"2023-02-16","last_seen":"2026-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001590750","name":"MIRAGEN THERAPEUTICS, INC.","url":"/issuer/0001590750","role":"Officer (Chief Business Officer)","n_filings":2,"first_seen":"2017-06-23","last_seen":"2018-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001693134","retrieved_at":"2026-08-22T15:57:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}